{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:30:39Z","timestamp":1793237439153,"version":"4.5.0"},"reference-count":254,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.bbagen.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T23:40:15Z","timestamp":1361230815000},"page":"3670-3695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2372,"title":["Natural products: A continuing source of novel drug leads"],"prefix":"10.1016","volume":"1830","author":[{"given":"Gordon M.","family":"Cragg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2013.02.008_bb0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1358\/dnp.2002.15.3.840015","article-title":"The beginnings of drug therapy: Ancient mesopotamian medicine","volume":"15","author":"Borchardt","year":"2002","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0010","series-title":"The pharmacology of chinese herbs","author":"Huang","year":"1999"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0015","series-title":"CRC handbook of ayurvedic medicinal plants","author":"Kapoor","year":"1990"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1289\/ehp.99107783","article-title":"Ancient-modern concordance in ayurvedic plants: Some examples","volume":"107","author":"Dev","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0025","series-title":"Medicinal plants of native America","author":"Moerman","year":"1986"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0030","series-title":"CRC ethnobotany desk reference","author":"Johnson","year":"1999"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0035","first-page":"965","article-title":"Medicinal plants in therapy","volume":"63","author":"Farnsworth","year":"1985","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0040","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1289\/ehp.01109s169","article-title":"The value of plants used in traditional medicine for drug discovery","volume":"109","author":"Fabricant","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0045","first-page":"983","article-title":"Natural products as leads for new pharmaceuticals","volume":"vol. 1","author":"Buss","year":"1995"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1473-3099(02)00239-6","article-title":"Epidemiology of drug-resistant malaria","volume":"2","author":"Wongsrichanalai","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0055","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/np50034a027","article-title":"Isolation of artemisinin (qinghaosu) from artemisia annua growing in the United States","volume":"47","author":"Klayman","year":"1985","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0060","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): An antimalarial drug from China","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0065","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2011.08.024","article-title":"Atermisinin: Discovery from the Chinese herbal garden","volume":"146","author":"Miller","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0070","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1021\/jm030571c","article-title":"A medicinal chemistry perspective on artemisinin and related endoperoxides","volume":"47","author":"O'Neill","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0075","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3390\/molecules15031705","article-title":"The molecular mechanism of action of artemisinin - the debate continues","volume":"15","author":"O'Neill","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0080","doi-asserted-by":"crossref","first-page":"e9582","DOI":"10.1371\/journal.pone.0009582","article-title":"Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0085","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02779","article-title":"Identification of an antimalarial synthetic trioxolane drug development candidate","volume":"430","author":"Vennerstrom","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0090","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/jm070149m","article-title":"Malaria-infected mice are cured by a single dose of novel artemisinin derivatives","volume":"50","author":"Posner","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0095","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/np200803m","article-title":"Natural products and traditional medicine: Turning on a paradigm","volume":"75","author":"Cordell","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0100","series-title":"Plants used against cancer","author":"Hartwell","year":"1982"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0105","first-page":"178","article-title":"Ethnobotany and drug discovery: The experience of the US National Cancer Institute","volume":"vol. 185","author":"Cragg","year":"1994"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0110","series-title":"Anticancer agents from natural products","first-page":"123","article-title":"The vinca alkaloids","author":"Gueritte","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0115","series-title":"Anticancer agents from natural products","first-page":"177","article-title":"The vinca alkaloids","author":"Roussi","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0120","series-title":"Anticancer agents from natural products","first-page":"71","article-title":"Podophyllotoxin and analogs","author":"Lee","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0125","series-title":"Anticancer agents from natural products","first-page":"95","article-title":"Podophyllotoxin and analogs","author":"Lee","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0130","series-title":"Anticancer agents from natural products","first-page":"89","article-title":"Taxol and its analogs","author":"Kingston","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0135","series-title":"Anticancer agents from natural products","first-page":"123","article-title":"Taxol and its analogs","author":"Kingston","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0140","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1073\/pnas.77.3.1561","article-title":"Taxol stabilizes microtubules in mouse fibroblast cells","volume":"77","author":"Schiff","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0145","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","article-title":"Abraxane, a novel cremophor-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer","volume":"17","author":"Green","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0150","unstructured":"A.C. Burman, R. Mukherjee, D. Khattar, M. Kumar, H. Bala, R.K. Shrivastava, Formulations of paclitaxel entrapped into nanoparticles of polymeric micelles, in: Patent EP 1216042, 12JUN2000."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0155","first-page":"130","article-title":"Taxoids: Cancer-fighting compounds from nature","volume":"10","author":"Kingston","year":"2007","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0160","series-title":"Anticancer agents from natural products","first-page":"5","article-title":"Camptothecin and its analogs","author":"Rahier","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0165","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.crci.2008.02.006","article-title":"The chemistry and biology of the maytansinoid antitumor agents","volume":"11","author":"Kirschning","year":"2008","journal-title":"C. R. Chimie"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0170","series-title":"Anticancer agents from natural products","first-page":"407","article-title":"Ansamitocins (maytansenoids)","author":"Yu","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0175","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cbpa.2009.03.023","article-title":"Potent antibody drug conjugates for cancer therapy","volume":"13","author":"Senter","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cbpa.2010.06.170","article-title":"Antibody-drug conjugates: Targeted drug delivery for cancer","volume":"14","author":"Alley","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0185","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cbpa.2010.06.175","article-title":"Design of next-generation protein therapeutics","volume":"14","author":"Caravella","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0190","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1358\/dof.2010.035.06.1497487","article-title":"Antibody-maytansinoid conjugates: A new strategy for the trreatment of cancer","volume":"35","author":"Lambert","year":"2010","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0195","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1358\/dof.2011.036.11.1711891","article-title":"Trastuzumab emtansine: Tumor-activated prodrug (tap) immunoconjugate oncolytic","volume":"36","author":"K\u00fcmler","year":"2011","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0200","series-title":"Five kingdoms, an illustrated guide to the phyla of life on earth","author":"Margulis","year":"1988"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1039\/a809395d","article-title":"Marine natural products","volume":"17","author":"Faulkner","year":"2000","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1039\/C2NP00090C","article-title":"Marine natural products","volume":"29","author":"Blunt","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0215","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/np040031y","article-title":"Marine natural products and related compounds in clinical and advanced preclinical trials","volume":"67","author":"Newman","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.chembiol.2011.12.014","article-title":"Lessons from the past and charting the future of marine natural products drug discovery and chemical biology","volume":"19","author":"Gerwick","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0225","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1586\/14737175.6.10.1423","article-title":"Ziconotide: A new nonopioid intrathecal analgesic for the treatment of chronic pain","volume":"6","author":"Wallace","year":"2006","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0230","doi-asserted-by":"crossref","first-page":"14562","DOI":"10.1073\/pnas.2335845100","article-title":"Efficient oxidative folding of conotoxins and the radiation of venomous cone snails","volume":"100","author":"Bulaj","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0235","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.toxicon.2010.12.003","article-title":"Cyclization of conotoxins to improve their biopharmaceutical properties","volume":"59","author":"Clark","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0240","series-title":"Anticancer agents from natural products","first-page":"215","article-title":"Ecteinascidin 743 (et-743); Yondelis\u2122, Aplidin and Kahalalide F","author":"Henriquez","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0245","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1039\/b808331m","article-title":"Development of Yondelis\u00ae (trabectedin, et-743). A semisynthetic process solves the supply problem","volume":"26","author":"Cuevas","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0250","series-title":"Anticancer agents from natural products","first-page":"291","article-title":"Ecteinascidin-743 (Yondelis(r)), Aplidine(r), and Irvalec(r)","author":"Cuevas","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0255","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1021\/cb200244t","article-title":"Meta-omic characterization of the marine invertebrate microbial consortium that produces the chemotherapeutic natural product et-743","volume":"6","author":"Rath","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0260","series-title":"Anticancer agents from natural products","first-page":"241","article-title":"Discovery of e7389, a fully synthetic macrocyclic ketone analog of halichondrin b","author":"Yu","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0265","series-title":"Anticancer agents from natural products","first-page":"137","article-title":"The bryostatins","author":"Newman","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0270","series-title":"Anticancer agents from natural products","first-page":"199","article-title":"The bryostatins","author":"Newman","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0275","first-page":"227","article-title":"Case history: Discovery of eribulin (halaven\u2122), a halichondrin b analogue that prolongs overall survival in patients with metastatic breast cancer","volume":"vol. 46","author":"Yu","year":"2011"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0280","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0140-6736(11)60070-6","article-title":"Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (embrace): A phase 3 open-label randomised study","volume":"377","author":"Cortes","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0285","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10637-010-9557-5","article-title":"Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: A California cancer consortium study","volume":"30","author":"Morgan","year":"2012","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0290","series-title":"Pharmaceutical innovation: Revolutionizing human health","first-page":"148","article-title":"Discovery and development of major drugs currently in use","author":"Scriabine","year":"1999"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0295","series-title":"Anticancer agents from natural products","first-page":"299","article-title":"Anthracyclines","author":"Arcamone","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0300","series-title":"Anticancer agents from natural products","first-page":"383","article-title":"Anthracyclines","author":"Arcamone","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0305","series-title":"Anticancer agents from natural products","first-page":"357","article-title":"Bleomycin group antitumor agents","author":"Hecht","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0310","series-title":"Antitmor agents from natural products","first-page":"451","article-title":"Bleomycin group antitumor agents","author":"Hecht","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0315","series-title":"Anticancer agents from natural products","first-page":"475","article-title":"The mitomycins","author":"Remers","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0320","series-title":"Anticancer agents from natural products","first-page":"451","article-title":"Enediynes","author":"Hamann","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0325","series-title":"Anticancer agents from natural products","first-page":"575","article-title":"Enediynes","author":"Hamann","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0330","series-title":"Anticancer agents from natural products","first-page":"499","article-title":"Staurosporines and structurally related indolocarbazoles as antitumor agents","author":"Prudhomme","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0335","series-title":"Anticancer agents from natural products","first-page":"647","article-title":"Staurosporines and structurally related indolocarbazoles as antitumor agents","author":"Prudhomme","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0340","first-page":"1","article-title":"Chemistry and biology of the carbazole alkaloids","volume":"vol. 65","author":"Knolker","year":"2008"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0345","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ja.2008.4","article-title":"Chemical biology of natural indolocarbazole products: 30years since the discovery of staurosporine","volume":"62","author":"Nakano","year":"2009","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0350","series-title":"Anticancer agents from natural products","first-page":"413","article-title":"Epothilone, a myxobacterial metabolite with promising antitumor activity","author":"Hofle","year":"2005"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0355","series-title":"Anticancer agents from natural products","first-page":"513","article-title":"Epothilone, a myxobacterial metabolite with promising antitumor activity","author":"Hofle","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0360","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1021\/jo0610053","article-title":"Small molecule natural products in the discovery of therapeutic agents: The synthesis connection","volume":"71","author":"Wilson","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0365","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1039\/B515619J","article-title":"Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents","volume":"24","author":"Altmann","year":"2007","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0370","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/cmdc.200600206","article-title":"The chemistry and biology of epothilones - the wheel keeps turning","volume":"2","author":"Altmann","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0375","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1021\/bi0616448","article-title":"Substrate tolerance of module 6 of the epothilone synthase","volume":"46","author":"Tse","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/annonc\/mdr336","article-title":"A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian urologic oncology group study p07a","volume":"23","author":"Chi","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0385","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/bjc.2011.499","article-title":"Phase i\/ii study of sagopilone (zk-epo) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer","volume":"106","author":"McMeekin","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0390","article-title":"Total synthesis and antitumor activity of zk-epo: The first fully synthetic epothilone in clinical development","volume":"45","author":"Klar","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0395","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/AAC.01609-08","article-title":"Pharmacokinetics of nikkomycin z after single rising oral doses","volume":"53","author":"Nix","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0400","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.mi.48.100194.002351","article-title":"Antibiotics that inhibit fungal cell wall development","volume":"48","author":"Debono","year":"1994","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0405","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0966-842X(00)88890-3","article-title":"The fungal cell wall as a drug target","volume":"3","author":"Georgopapadakou","year":"1995","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0410","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1021\/jm00017a012","article-title":"Semisynthetic chemical modification of the antifungal lipopeptide echinocandin b (ecb): Structure-activity studies of the lipophilic and geometric parameters of polyarylated acyl analogs of ecb","volume":"38","author":"Debono","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0415","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.7164\/antibiotics.45.1853","article-title":"Pneumocandins from Zalerion arboricola I. Discovery and isolation","volume":"45","author":"Schwartz","year":"1992","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0420","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.7164\/antibiotics.45.1867","article-title":"Pneumocandins from Zalerion arboricola II. Modification of product spectrum by mutation and medium manipulation","volume":"45","author":"Masurekar","year":"1992","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0425","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.7164\/antibiotics.45.1886","article-title":"Pneumocandins from Zalerion arboricola IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species","volume":"45","author":"Schmatz","year":"1992","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0430","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1128\/AAC.36.8.1648","article-title":"In vitro antifungal activities and in vivo efficacies of 1,3-beta-d-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin b, and L-687,781, a papulacandin","volume":"36","author":"Bartizal","year":"1992","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0435","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0065-3233(01)56011-8","article-title":"Glucan synthase inhibitors as antifungal agents","volume":"36","author":"Kurtz","year":"2001","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0440","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1592\/phco.28.5.614","article-title":"Current options in antifungal pharmacotherapy","volume":"28","author":"Mohr","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0445","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14728214.2011.607811","article-title":"Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations","volume":"16","author":"Pitman","year":"2011","journal-title":"Exp. Opin. Emerging Drugs"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0450","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.chembiol.2011.01.009","article-title":"Confronting the challenges of natural product-based antifungal discovery","volume":"18","author":"Roemer","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0455","doi-asserted-by":"crossref","first-page":"e35478","DOI":"10.1371\/journal.pone.0035478","article-title":"Microcolony imaging of Aspergillus fumigatus treated with echinocandins reveals both fungistatic and fungicidal activities","volume":"7","author":"Ingham","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0460","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/np0580560","article-title":"Alkaloids from amphibian skins. A tabulation of over eight hundred compounds","volume":"68","author":"Daly","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0465","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspecturn venom","volume":"267","author":"Eng","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0470","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1358\/dof.2008.033.01.1164951","article-title":"Liraglutide","volume":"33","author":"Gallwitz","year":"2008","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0475","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"41","key":"10.1016\/j.bbagen.2013.02.008_bb0480","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/cen-v081n041.p077","article-title":"Rediscovering natural products","volume":"81","author":"Rouhi","year":"2003","journal-title":"Chem. Eng. News"},{"issue":"25","key":"10.1016\/j.bbagen.2013.02.008_bb0485","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/cen-v084n025.p056","article-title":"Improving efficiency","volume":"84","author":"Borman","year":"2006","journal-title":"Chem. Eng. News"},{"issue":"40","key":"10.1016\/j.bbagen.2013.02.008_bb0490","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/cen-v080n002.p023","article-title":"Organic lab sparks drug discovery","volume":"80","author":"Borman","year":"2002","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0495","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1021\/ar068018n","article-title":"Applications of total synthesis to problems in neurodegeneration: Fascinating chemistry along the way","volume":"39","author":"Wilson","year":"2006","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0500","first-page":"311","article-title":"Le cycle de division cellulaire et sa regulation","volume":"5","author":"Meijer","year":"2003","journal-title":"Oncologie"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0505","first-page":"355","article-title":"Natural product sources of drugs: Plants, microbes, marine organisms and animals","volume":"vol. 1","author":"Cragg","year":"2006"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0510","first-page":"2","article-title":"Plant-derived natural products in drug discovery and development","volume":"vol. 534","author":"Balandrin","year":"1993"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0515","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0167-7799(02)02080-2","article-title":"Plants and human health in the twenty-first century","volume":"20","author":"Raskin","year":"2002","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0520","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10295-006-0115-2","article-title":"New drugs from marine microbes: The tide is turning","volume":"33","author":"Newman","year":"2006","journal-title":"J. Ind. Microbiol. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0525","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/S0040-4020(01)89673-3","article-title":"Alkaloids from the Antarctic sponge Kirkpatrickia varialosa. : Part 1: Variolin B, a new antitumour and antiviral compound.","volume":"50","author":"Perry","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0530","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1016\/S0040-4020(01)89674-5","article-title":"Alkaloids from the Antarctic sponge Kirkpatrickia varialosa. Part 2: Variolin a and n(3\u2032)-methyl tetrahydrovariolin B","volume":"50","author":"Trimurtulu","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0535","doi-asserted-by":"crossref","first-page":"10020","DOI":"10.1021\/jo035332b","article-title":"Total syntheses of variolin B and deoxyvariolin B","volume":"68","author":"Ahaidar","year":"2003","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0540","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1021\/ja0588508","article-title":"Palmerolide A, a cytotoxic macrolide from the Antarctic tunicate Synoicum adareanum","volume":"128","author":"Diyabalanage","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0545","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1002\/anie.200702243","article-title":"Synthesis of the originally proposed and revised structures of palmerolide A","volume":"46","author":"Nicolaou","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0550","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1039\/B800164M","article-title":"Molecules derived from the extremes of life","volume":"26","author":"Wilson","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0555","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1021\/jm020359t","article-title":"Elicitation, a new window into plant chemodiversity and phytochemical drug discovery","author":"Poulev","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0560","doi-asserted-by":"crossref","first-page":"14276","DOI":"10.1021\/ja066787w","article-title":"Directed biosynthesis of alkaloid analogs in the medicinal plant Catharanthus roseus","volume":"128","author":"McCoy","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0565","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1021\/ja077190z","article-title":"Strictosidine synthase: Mechanism of a Pictet-Spengler catalyzing enzyme","volume":"130","author":"Maresh","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0570","first-page":"330","article-title":"Natural products from plant cell cultures","volume":"65","author":"McCoy","year":"2008","journal-title":"Prog. Drug Res."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0575","doi-asserted-by":"crossref","first-page":"16751","DOI":"10.1074\/jbc.M111.225383","article-title":"A stereoselective hydroxylation step of alkaloid biosynthesis by a unique cytochrome p450 in Catharanthus roseus","volume":"286","author":"Giddings","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0580","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.phytochem.2011.07.001","article-title":"A virus-induced gene silencing approach to understanding alkaloid metabolism in Catharanthus roseus","volume":"72","author":"Liscombe","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0585","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.phytochem.2010.12.020","article-title":"Unusual withanolides from aeroponically grown Withania somnifera","volume":"72","author":"Xu","year":"2011","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0590","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.276.5313.734","article-title":"A molecular view of microbial diversity and the biosphere","volume":"276","author":"Pace","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0595","series-title":"Biology of microorganisms","author":"Madigan","year":"1996"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0600","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/np0401664","article-title":"Microbial genomics as a guide to drug discovery and structural elucidation: Eco-02301, a novel antifungal agent, as an example","volume":"68","author":"McAlpine","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0605","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nchembio731","article-title":"Discovery of a new peptide natural product by Streptomyces coelicolor genome mining","volume":"1","author":"Lautru","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0610","doi-asserted-by":"crossref","first-page":"15681","DOI":"10.1073\/pnas.252630999","article-title":"Cultivating the uncultured","volume":"99","author":"Zengler","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0615","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1073\/pnas.0700962104","article-title":"Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica","volume":"104","author":"Udwary","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0620","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1039\/b817069j","article-title":"Genomic basis for natural product biosynthetic diversity in the actinomycetes","volume":"26","author":"Nett","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0625","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1128\/AEM.02811-06","article-title":"Phylogenetic diversity of Gram-positive bacteria cultured from marine sediments","volume":"73","author":"Gontang","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0630","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1039\/c2np00084a","article-title":"Advances in Aspergillus secondary metabolite research in the post-genomic era","volume":"29","author":"Sanchez","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0635","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AEM.66.6.2541-2547.2000","article-title":"Cloning the soil metagenome: A strategy for accessing the genetic and functional diversity of uncultured microorganisms","volume":"66","author":"Rondon","year":"2000","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0640","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.1093857","article-title":"Environmental genome shotgun sequencing of the Sargasso sea","volume":"304","author":"Venter","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0645","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1039\/b817078a","article-title":"Metagenomic approaches to natural products from free-living and symbiotic organisms","volume":"26","author":"Brady","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0650","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1371\/journal.pbio.0050016","article-title":"The Sorcerer II global ocean sampling expedition: Expanding the universe of protein families","volume":"5","author":"Yooseph","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0655","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1126\/science.307.5715.1558d","article-title":"Life in the air","volume":"307","author":"Holden","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0660","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1073\/pnas.1205361109","article-title":"Microbial genome mining answers longstanding biosynthetic questions","volume":"109","author":"Crawford","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0665","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1039\/B703499G","article-title":"Metabolites from symbiotic bacteria","volume":"26","author":"Piel","year":"2009","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0670","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1021\/ja808889k","article-title":"Pederin-type pathways of uncultivated bacterial symbionts: Analysis of o-methyltransferases and generation of a biosynthetic hybrid","volume":"131","author":"Zimmermann","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0675","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/anie.200351053","article-title":"Structural and functional analysis of pantocin A: An antibiotic from Pantoea agglomerans discovered by heterologous expression of cloned genes","volume":"42","author":"Jin","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0680","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0167-7799(00)01539-0","article-title":"The biotechnological potential of piezophiles","volume":"19","author":"Abe","year":"2001","journal-title":"Trends Biotechnol."},{"issue":"38","key":"10.1016\/j.bbagen.2013.02.008_bb0685","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/cen-v084n038.p014","article-title":"Microbes live near undersea CO2 lake","volume":"84","author":"Amato","year":"2006","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0690","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nbt0698-593","article-title":"Extremophiles","volume":"16","author":"Persidis","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0695","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1128\/JB.185.13.3683-3689.2003","article-title":"Extremophiles 2002","volume":"185","author":"Rossi","year":"2003","journal-title":"J. Bacteriol."},{"issue":"4","key":"10.1016\/j.bbagen.2013.02.008_bb0700","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1021\/cen-v085n004.p020","article-title":"New Zealand plays to its strengths","volume":"85","author":"Short","year":"2007","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0705","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0958-1669(02)00317-8","article-title":"Low-temperature extremophiles and their applications","volume":"13","author":"Cavicchioli","year":"2002","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0710","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0167-7799(02)02073-5","article-title":"The production of biocatalysts and biomolecules from extremophiles","volume":"20","author":"Schiraldi","year":"2002","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0715","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1369-5274(03)00060-2","article-title":"Extremophiles as a source for novel enzymes","volume":"6","author":"van den Burg","year":"2003","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0720","first-page":"223","article-title":"The biocatalytic potential of extremophiles and extremozymes","volume":"42","author":"Gomes","year":"2004","journal-title":"Food Technol. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0725","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1389-1723(04)00290-7","article-title":"Extreme catalysts from low-temperature environments","volume":"98","author":"Hoyoux","year":"2004","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0730","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/bst0320193","article-title":"Alkalithermophiles","volume":"32","author":"Wiegel","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0735","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0923-2508(03)00114-1","article-title":"The microbiology of acidic mine waters","volume":"154","author":"Johnson","year":"2003","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0740","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/np049975d","article-title":"Novel sesquiterpenoid matrix metalloproteinase-3 inhibitors from an acid mine waste extremophile","volume":"67","author":"Stierle","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0745","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1021\/ol049852k","article-title":"Berkeleydione and berkeleytrione, new bioactive metabolites from an acid mine organism","volume":"6","author":"Stierle","year":"2004","journal-title":"Org. Lett."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0750","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1572-5995(05)80074-2","article-title":"Bioprospecting in the Berkeley pit: Bioactive metabolites from acid mine waste extremophiles","volume":"32","author":"Stierle","year":"2005","journal-title":"Stud. Nat. Prod. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0755","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1021\/np2003066","article-title":"Berkeleyones and related meroterpenes from a deep water acid mine waste fungus that inhibit the production of interleukin 1-\u03b2 from induced inflammasomes","volume":"74","author":"Stierle","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0760","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1039\/b100918o","article-title":"Endophytes: A rich source of functional metabolites","volume":"18","author":"Tan","year":"2001","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0765","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/np030397v","article-title":"Natural products from endophytic microorganisms","volume":"67","author":"Strobel","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0770","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/np058128n","article-title":"Natural products from plant-associated microorganisms: Distribution, structural diversity, bioactivity, and implications of their occurrence","volume":"69","author":"Gunatilaka","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0775","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-1097(03)00426-9","article-title":"Kakadumycins, novel antibiotics from Streptomyces sp. NRRL 30566, an endophyte of Grevillea pteridifolia","volume":"224","author":"Castillo","year":"2003","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0780","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0031-9422(00)00408-8","article-title":"Ambuic acid, a highly functionalized cyclohexenone with antifungal activity from Pestalotiopsis spp. and Monochaetia sp","volume":"56","author":"Li","year":"2001","journal-title":"Phytochemistry"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0785","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1021\/np030353m","article-title":"Aspochalasins i, j, and k: Three new cytotoxic cytochalasans of Aspergillus flavipes from the rhizosphere of Ericameria laricifolia of the sonoran desert","volume":"67","author":"Zhou","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0790","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.8097061","article-title":"Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of pacific yew","volume":"260","author":"Stierle","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0795","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1017\/S0953756297005078","article-title":"Stimulation of taxol production in liquid cultures of Pestalotiopsis microspora","volume":"102","author":"Li","year":"1998","journal-title":"Mycol. Res."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0800","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/np0502802","article-title":"An endophytic fungus from Nothapodytes foetida that produces camptothecin","volume":"68","author":"Puri","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0805","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1139\/W05-122","article-title":"Bioreactor studies on the endophytic fungus Entrophosphora infrequens for the production of an anticancer alkaloid camptothecin","volume":"52","author":"Amna","year":"2006","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0810","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/np060174f","article-title":"Endophyte fungal isolates from Podophyllum peltatum produce podophyllotoxin","volume":"69","author":"Eyberger","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0815","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jbiotec.2005.10.015","article-title":"The endophytic fungus Trametes hirsuta as a novel alternative source of podophyllotoxin and related tetralin lignans","volume":"122","author":"Puri","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0820","first-page":"214","article-title":"Isolation of a fungus producing vinblastine","volume":"20","author":"Guo","year":"1998","journal-title":"J. Yunnan Univ."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0825","first-page":"805","article-title":"Preliminary study on the isolation of endophytic fungus of Catharanthus roseus and its fermentation to produce products of therapeutic value","volume":"31","author":"Zhang","year":"2000","journal-title":"Zhong Cao Yao (Chinese Tradit. Herb. Drugs)"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0830","first-page":"79","article-title":"Preliminary study of a vincristine-producing endophytic fungus isolated from leaves of Catharanthus roseus","volume":"35","author":"Yang","year":"2004","journal-title":"Zhong Cao Yao (Chinese Tradit. Herb. Drugs)"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0835","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.chembiol.2005.10.008","article-title":"Genomic mining for Aspergillus natural products","volume":"13","author":"Bok","year":"2006","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0840","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1039\/B603084J","article-title":"Natural products of filamentous fungi: Enzymes, genes, and their regulation","volume":"24","author":"Hoffmeister","year":"2007","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0845","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1128\/AEM.68.10.5005-5011.2002","article-title":"Widespread and persistent populations of a major new marine Actinomycete taxon in ocean sediments","volume":"68","author":"Mincer","year":"2002","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0850","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/anie.200390115","article-title":"Salinosporamide A: A highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora","volume":"42","author":"Feling","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0855","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1021\/ja0558948","article-title":"Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus \"Marinispora\"","volume":"128","author":"Kwon","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0860","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1021\/np0604580","article-title":"Saliniketals A and B, bicyclic polyketides from the marine actinomycete Salinispora arenicola","volume":"70","author":"Williams","year":"2007","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0865","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1021\/ol070294u","article-title":"Thalassospiramides A and B, immunosuppressive peptides from the marine bacterium Thalassopira sp","volume":"9","author":"Oh","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0870","doi-asserted-by":"crossref","first-page":"12512","DOI":"10.1002\/chem.201001279","article-title":"Antibacterials from the sea","volume":"16","author":"Hughes","year":"2010","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0875","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.copbio.2010.09.013","article-title":"The expanding role of marine microbes in pharmaceutical development","volume":"21","author":"Waters","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0880","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10126-010-9294-y","article-title":"Culturability and secondary metabolite diversity of extreme microbes: Expanding contribution of deep sea and deep-sea vent microbes to natural product discovery","volume":"13","author":"Pettit","year":"2011","journal-title":"Mar. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0885","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1039\/b310175b","article-title":"Metabolites from symbiotic bacteria","volume":"21","author":"Piel","year":"2004","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0890","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1021\/np049612d","article-title":"Exploring the chemistry of uncultivated bacterial symbionts: Antitumor polyketides of the pederin family","volume":"68","author":"Piel","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0895","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1128\/JB.186.5.1280-1286.2004","article-title":"Evidence for a symbiosis island involved in horizontal acquisition of pederin biosynthetic capabilities by the bacterial symbiont of Paederus fuscipes beetles","volume":"186","author":"Piel","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0900","doi-asserted-by":"crossref","first-page":"16222","DOI":"10.1073\/pnas.0405976101","article-title":"Antitumor polyketide biosynthesis by an uncultivated bacterial symbiont of the marine sponge Theonella swinhoei","volume":"101","author":"Piel","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0905","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1016\/j.bmc.2011.07.017","article-title":"Highlights of marine invertebrate-derived biosynthetic products: Their biomedical potential and possible production by microbial associants","volume":"19","author":"Radjasa","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0910","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/nature03997","article-title":"Pathogenic fungus harbours endosymbiotic bacteria for toxin production","volume":"437","author":"Partida-Martinez","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0915","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1128\/AEM.01784-06","article-title":"Rhizonin, the first mycotoxin isolated from the zygomycota, is not a fungal metabolite but is produced by bacterial endosymbionts","volume":"73","author":"Partida-Martinez","year":"2007","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0920","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1099\/ijs.0.64660-0","article-title":"Burkholderia rhizoxinica sp. nov. and Burkholderia endofungorum sp. nov., bacterial endosymbionts of the plant-pathogenic fungus Rhizopus microsporous","volume":"57","author":"Partida-Martinez","year":"2007","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0925","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1128\/AEM.01765-08","article-title":"Global distribution and evolution of a toxinogenic Burkholderia-Rhizopus symbiosis","volume":"75","author":"Lackner","year":"2009","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0930","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/jo000849y","article-title":"Natural product biosynthesis: A new interface between enzymology and medicine","volume":"65","author":"Khosla","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0935","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1039\/a909079g","article-title":"Polyketide biosynthesis: A millennium review","volume":"18","author":"Staunton","year":"2001","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0940","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1126\/science.1094318","article-title":"Polyketide and nonribosomal peptide antibiotics: Modularity and versatility","volume":"303","author":"Walsh","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0945","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1021\/ar7000414","article-title":"The chemical versatility of natural-product assembly lines","volume":"41","author":"Walsh","year":"2007","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0950","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nature03194","article-title":"Lessons from natural molecules","volume":"432","author":"Clardy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0955","series-title":"Anticancer agents from natural products","first-page":"671","article-title":"Combinatorial biosynthesis of anticancer natural products","author":"Van Lanen","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0960","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0378-1119(00)00149-9","article-title":"Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum","volume":"249","author":"Julien","year":"2000","journal-title":"Gene"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0965","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1074-5521(00)00075-2","article-title":"The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum so ce90","volume":"7","author":"Molnar","year":"2000","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0970","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/bit.10202","article-title":"Optimizing the heterologous production of epothilone D in Myxococcus xanthus","volume":"78","author":"Lau","year":"2002","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0975","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/(SICI)1521-3773(20000103)39:1<44::AID-ANIE44>3.0.CO;2-L","article-title":"The art and science of total synthesis at the dawn of the twenty-first century","volume":"39","author":"Nicolaou","year":"2000","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0980","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1002\/1521-3773(20011217)40:24<4770::AID-ANIE4770>3.0.CO;2-T","article-title":"Total synthesis of nominal diazonamides - part 2: On the true structure and origin of natural isolates","volume":"40","author":"Li","year":"2001","journal-title":"Angew. Chem. Int. Ed."},{"issue":"9","key":"10.1016\/j.bbagen.2013.02.008_bb0985","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1021\/cen-v082n009.p033","article-title":"Scaled-up synthesis of discodermolide","volume":"82","author":"Freemantle","year":"2004","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.bbagen.2013.02.008_bb0990","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/op034134j","article-title":"Large-scale synthesis of the anti-cancer marine natural product (+)-discodermolide. Part 5: Linkage of fragments c1-6 and c7-24 and finale.","volume":"8","author":"Mickel","year":"2004","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.bbagen.2013.02.008_bb0995","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1358\/dof.2010.035.010.1524349","article-title":"Brentuximab vedotin","volume":"35","author":"Copeland","year":"2010","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1000","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1039\/c0ob01127d","article-title":"Structure-activity studies of the pelorusides: New congeners and semi-synthetic analogues","volume":"9","author":"Singh","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/asia.201000541","article-title":"Total synthesis and biological evaluation of a series of macrocyclic hybrids and analogues of the antimitotic natural products dictyostatin, discodermolide, and taxol","volume":"6","author":"Paterson","year":"2011","journal-title":"Chem. Asian J."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1010","first-page":"777","article-title":"Synthesis of polyketide natural products and analogs as promising anticancer agents","volume":"13","author":"Dalby","year":"2010","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1015","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.1016\/j.tet.2009.04.003","article-title":"Spongipyran synthetic studies. Evolution of a scalable total synthesis of (+)-spongistatin 1","volume":"65","author":"Smith","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1020","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/anie.200907112","article-title":"Total synthesis of palau'amine","volume":"49","author":"Seiple","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1025","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/(SICI)1521-3773(19980605)37:10<1418::AID-ANIE1418>3.0.CO;2-5","article-title":"Synthesis and biological activity of sarcodictyins","volume":"37","author":"Nicolaou","year":"1998","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1030","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1021\/jm00120a002","article-title":"Methods for drug discovery: Development of potent, selective, orally effective cholecystokinin antagonists","author":"Evans","year":"1988","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S1359-6446(05)03419-7","article-title":"Protein structure similarity clustering and natural product structure as guiding principles in drug discovery","volume":"10","author":"Koch","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1040","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1021\/ja002033k","article-title":"Natural product-like combinatorial libraries based on privileged structures. 1. General principles and solid-phase synthesis of benzopyrans","volume":"122","author":"Nicolaou","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1045","doi-asserted-by":"crossref","first-page":"9968","DOI":"10.1021\/ja0020355","article-title":"Natural product-like combinatorial libraries based on privileged structures. 3. The \"libraries from libraries\" principle for diversity enhancement of benzopyran libraries","volume":"122","author":"Nicolaou","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1050","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/ja002034c","article-title":"Natural product-like combinatorial libraries based on privileged structures. 2. Construction of a 10 000-membered benzopyran library by directed split-and-pool chemistry using nanokans and optical encoding","volume":"122","author":"Nicolaou","year":"2000","journal-title":"J. Am. Chem. Soc."},{"issue":"43","key":"10.1016\/j.bbagen.2013.02.008_bb1055","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1021\/cen-v081n043.p045","article-title":"The many faces of combinatorial chemistry","volume":"81","author":"Borman","year":"2003","journal-title":"Chem. Eng. News"},{"issue":"40","key":"10.1016\/j.bbagen.2013.02.008_bb1060","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/cen-v082n040.p032","article-title":"Rescuing combichem. Diversity-oriented synthesis (dos) aims to pick up where traditional combinatorial chemistry left off.","volume":"82","author":"Borman","year":"2004","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1065","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1021\/cr900019j","article-title":"Impact of natural products on developing new anti-cancer agents","volume":"109","author":"Cragg","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1070","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1002\/anie.201007004","article-title":"Biology-oriented synthesis","volume":"50","author":"Wetzel","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1075","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2174\/138945011798109482","article-title":"Exploring and exploiting biologically relevant chemical space","volume":"12","author":"Eberhardt","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1080","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1126\/science.1089946","article-title":"Generating diverse skeletons of small molecules combinatorially","volume":"302","author":"Burke","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/anie.200300626","article-title":"A planning strategy for diversity-oriented synthesis","volume":"43","author":"Burke","year":"2004","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1090","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2174\/0929867023368773","article-title":"Natural product guided compound library development","volume":"9","author":"Breinbauer","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1095","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/1521-3773(20020816)41:16<2878::AID-ANIE2878>3.0.CO;2-B","article-title":"From protein domains to drug candidates\u2014natural products as guiding principles in the design and synthesis of compound libraries","volume":"41","author":"Breinbauer","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/1521-3773(20020118)41:2<307::AID-ANIE307>3.0.CO;2-1","article-title":"Natural products are biologically validated starting points in structural space for compound library development: Solid-phase synthesis of dysidiolide-derived phosphatase inhibitors","volume":"41","author":"Brohm","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1105","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.copbio.2004.09.002","article-title":"Natural products as a hunting ground for combinatorial chemistry","volume":"15","author":"Ganesan","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1110","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/1521-3773(20020402)41:7<1174::AID-ANIE1174>3.0.CO;2-V","article-title":"Natural product derived receptor tyrosine kinase inhibitors: Identification of igf1r, tie-2, and vegfr-3 inhibitors","volume":"41","author":"Stahl","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1115","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1002\/1521-3773(20021004)41:19<3616::AID-ANIE3616>3.0.CO;2-F","article-title":"Solid-phase synthesis and biological evaluation of a pepticinnamin E library","volume":"41","author":"Thutewohl","year":"2002","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impact of natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio.911","article-title":"A diversity-oriented synthesis approach to macrocycles via oxidative ring expansion","volume":"8","author":"Kopp","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1130","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/np200687v","article-title":"Drug-like properties: Guiding principles for the design of natural product libraries","volume":"75","author":"Camp","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1135","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1002\/anie.200501080","article-title":"The impact of bacterial genomics on natural product research","volume":"44","author":"Bode","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1140","doi-asserted-by":"crossref","first-page":"e1000351","DOI":"10.1371\/journal.pcbi.1000351","article-title":"Towards prediction of metabolic products of polyketide synthases: An in silico analysis","volume":"5","author":"Yadav","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1145","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1039\/C0NP90032J","article-title":"A sea of biosynthesis: Marine natural products meet the molecular age","volume":"28","author":"Lane","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1150","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1039\/c2np20016c","article-title":"Insights from the sea: Structural biology of marine polyketide synthases","volume":"29","author":"Akey","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/ja.2006.74","article-title":"Genomic analyses lead to novel secondary metabolites. Part 3. Eco-0501, a novel antibacterial of a new class","volume":"59","author":"Banskota","year":"2006","journal-title":"J. Antibiot."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1160","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/nbt1266","article-title":"New antibiotics from bacterial natural products","volume":"24","author":"Clardy","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tim.2007.04.001","article-title":"New aspects of natural products in drug discovery","volume":"15","author":"Lam","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1170","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1365-2958.2007.05627.x","article-title":"Deciphering regulatory mechanisms for secondary metabolite production in the myxobacterium Sorangium cellulosum so ce56","volume":"63","author":"Rachid","year":"2007","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1175","doi-asserted-by":"crossref","first-page":"e37416","DOI":"10.1371\/journal.pone.0037416","article-title":"Pretubulysin: From hypothetical biosynthetic intermediate to potential lead in tumor therapy","volume":"7","author":"Herrmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1180","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nature04784","article-title":"Platensimycin is a selective fabf inhibitor with potent antibiotic properties","volume":"441","author":"Wang","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1185","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1002\/anie.200701058","article-title":"Isolation and structure of platencin: A fabh and fabf dual inhibitor with potent broad-spectrum antibiotic activity","author":"Jayasuriya","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/AAC.50.2.519-526.2006","article-title":"Discovery of fabh\/fabf inhibitors from natural products","volume":"50","author":"Young","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1195","doi-asserted-by":"crossref","first-page":"5449","DOI":"10.1021\/ol062041r","article-title":"Discovery of lucensimycins A and B from Streptomyces lucensis ma7349 using an antisense strategy","volume":"8","author":"Singh","year":"2006","journal-title":"Org. Lett."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1200","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1002\/anie.200603892","article-title":"Total synthesis of platensimycin","volume":"45","author":"Nicolaou","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1205","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1002\/anie.200700586","article-title":"Asymmetric total syntheses of platensimycin","volume":"46","author":"Nicolaou","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1210","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1002\/anie.200701548","article-title":"Adamanta-platensimycin: A bioactive analogue of platensimycin","volume":"46","author":"Nicolaou","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/np100635f","article-title":"Platensimycin and platencin congeners from Streptomyces platensis","volume":"74","author":"Zhang","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1220","first-page":"1316","article-title":"Legal and ethical issues involving marine biodiscovery and development","volume":"vol. 2","author":"Cragg","year":"2012"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1225","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1039\/c2np20091k","article-title":"The impact of the united nations convention on biological diversity on natural products research","volume":"29","author":"Cragg","year":"2012","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: Confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1235","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrd3368","article-title":"Impact of high-throughput screening in biomedical research","volume":"10","author":"Macarron","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1240","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrd2008","article-title":"Cellular imaging in drug discovery","volume":"5","author":"Lang","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1245","first-page":"132","article-title":"Discovery and development of antineoplastic agents from natural sources","volume":"vol. 3","author":"Suffness","year":"1989"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1250","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/S0960-894X(99)00376-5","article-title":"Total synthesis of the potent proteasome inhibitor epoximicin: A useful tool for understanding proteosome biology","volume":"9","author":"Sin","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1255","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1358\/dof.2009.034.09.1414774","article-title":"Carfilzomib","volume":"34","author":"Davies","year":"2009","journal-title":"Drugs Future"},{"key":"10.1016\/j.bbagen.2013.02.008_bb1260","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1039\/c0np00061b","article-title":"Secondary metabolites of fungi from marine habitats","volume":"28","author":"Rateb","year":"2011","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1265","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.biotechadv.2011.03.001","article-title":"Bio-mining the microbial treasures of the ocean: New natural products","volume":"29","author":"Imhoff","year":"2011","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bbagen.2013.02.008_bb1270","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ja.2012.27","article-title":"Thoughts and facts about antibiotics: Where we are now and where we are heading","volume":"65","author":"Berdy","year":"2012","journal-title":"J. Antibiot."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416513000512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416513000512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T17:50:03Z","timestamp":1644342603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416513000512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":254,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0304416513000512"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.02.008","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718012888.793477215","asserted-by":"object"}]},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural products: A continuing source of novel drug leads","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2013.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}